BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 31242345)

  • 1. Sarcopenia in Chronic Liver Disease: Impact on Outcomes.
    Ooi PH; Hager A; Mazurak VC; Dajani K; Bhargava R; Gilmour SM; Mager DR
    Liver Transpl; 2019 Sep; 25(9):1422-1438. PubMed ID: 31242345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sarcopenia in Children With End-Stage Liver Disease on the Transplant Waiting List.
    Woolfson JP; Perez M; Chavhan GB; Johara FT; Lurz E; Kamath BM; Ng VL
    Liver Transpl; 2021 May; 27(5):641-651. PubMed ID: 33460522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Prior Bariatric Surgery on Perioperative Liver Transplant Outcomes.
    Idriss R; Hasse J; Wu T; Khan F; Saracino G; McKenna G; Testa G; Trotter J; Klintmalm G; Asrani SK
    Liver Transpl; 2019 Feb; 25(2):217-227. PubMed ID: 30369002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretransplant Sarcopenia in Patients With NASH Cirrhosis Does Not Impact Rehospitalization or Mortality.
    Aby ES; Lee E; Saggi SS; Viramontes MR; Grotts JF; Agopian VG; Busuttil RW; Saab S
    J Clin Gastroenterol; 2019 Oct; 53(9):680-685. PubMed ID: 30180152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nutrition and the transplant candidate.
    Mazurak VC; Tandon P; Montano-Loza AJ
    Liver Transpl; 2017 Nov; 23(11):1451-1464. PubMed ID: 29072825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical exercise in cirrhotic patients: Towards prehabilitation on waiting list for liver transplantation. A systematic review and meta-analysis.
    Brustia R; Savier E; Scatton O
    Clin Res Hepatol Gastroenterol; 2018 Jun; 42(3):205-215. PubMed ID: 29162460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. End-stage liver disease patients with MELD >40 have higher waitlist mortality compared to Status 1A patients.
    Ahn J; Bhuket T; Mosadeghi S; Frenette C; Liu B; Wong RJ
    Hepatol Int; 2016 Sep; 10(5):838-46. PubMed ID: 27221700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differing Impact of Sarcopenia and Frailty in Nonalcoholic Steatohepatitis and Alcoholic Liver Disease.
    Bhanji RA; Narayanan P; Moynagh MR; Takahashi N; Angirekula M; Kennedy CC; Mara KC; Dierkhising RA; Watt KD
    Liver Transpl; 2019 Jan; 25(1):14-24. PubMed ID: 30257063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exercise and physical activity for patients with end-stage liver disease: Improving functional status and sarcopenia while on the transplant waiting list.
    Duarte-Rojo A; Ruiz-Margáin A; Montaño-Loza AJ; Macías-Rodríguez RU; Ferrando A; Kim WR
    Liver Transpl; 2018 Jan; 24(1):122-139. PubMed ID: 29024353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disability in patients with end-stage liver disease: Results from the functional assessment in liver transplantation study.
    Samoylova ML; Covinsky KE; Haftek M; Kuo S; Roberts JP; Lai JC
    Liver Transpl; 2017 Mar; 23(3):292-298. PubMed ID: 27884053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sarcopenia in liver transplantation: A review.
    Meeks AC; Madill J
    Clin Nutr ESPEN; 2017 Dec; 22():76-80. PubMed ID: 29415839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low psoas muscle index as an unfavorable factor in children with end-stage liver disease undergoing liver transplantation.
    Jitwongwai S; Lertudomphonwanit C; Junhasavasdikul T; Fuangfa P; Tanpowpong P; Gesprasert G; Treepongkaruna S
    Pediatr Transplant; 2021 Aug; 25(5):e13996. PubMed ID: 33734542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value.
    Tandon P; Ney M; Irwin I; Ma MM; Gramlich L; Bain VG; Esfandiari N; Baracos V; Montano-Loza AJ; Myers RP
    Liver Transpl; 2012 Oct; 18(10):1209-16. PubMed ID: 22740290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sarcopenia in Cirrhosis: Fallout on Liver Transplantation.
    Kumar V; Benjamin J; Shasthry V; Subramanya Bharathy KG; Sinha PK; Kumar G; Pamecha V
    J Clin Exp Hepatol; 2020; 10(5):467-476. PubMed ID: 33029056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sarcopenia in Children With End-Stage Liver Disease.
    Lurz E; Patel H; Frimpong RG; Ricciuto A; Kehar M; Wales PW; Towbin AJ; Chavhan GB; Kamath BM; Ng VL
    J Pediatr Gastroenterol Nutr; 2018 Feb; 66(2):222-226. PubMed ID: 29356766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malnutrition and sarcopenia predict post-liver transplantation outcomes independently of the Model for End-stage Liver Disease score.
    Kalafateli M; Mantzoukis K; Choi Yau Y; Mohammad AO; Arora S; Rodrigues S; de Vos M; Papadimitriou K; Thorburn D; O'Beirne J; Patch D; Pinzani M; Morgan MY; Agarwal B; Yu D; Burroughs AK; Tsochatzis EA
    J Cachexia Sarcopenia Muscle; 2017 Feb; 8(1):113-121. PubMed ID: 27239424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher Mortality in Pediatric Liver Transplant Candidates With Sarcopenia.
    Boster JM; Browne LP; Pan Z; Zhou W; Ehrlich PF; Sundaram SS
    Liver Transpl; 2021 Jun; 27(6):808-817. PubMed ID: 33621376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter study to define sarcopenia in patients with end-stage liver disease.
    Carey EJ; Lai JC; Wang CW; Dasarathy S; Lobach I; Montano-Loza AJ; Dunn MA;
    Liver Transpl; 2017 May; 23(5):625-633. PubMed ID: 28240805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of Sarcopenia After Pediatric Liver Transplantation Is Associated With Poorer Growth and Recurrent Hospital Admissions.
    Mager DR; Hager A; Ooi PH; Siminoski K; Gilmour SM; Yap JYK
    JPEN J Parenter Enteral Nutr; 2019 Feb; 43(2):271-280. PubMed ID: 30035306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mechanism based approach to management of children with end-stage liver disease.
    Haafiz AB
    Expert Rev Gastroenterol Hepatol; 2017 Dec; 11(12):1085-1094. PubMed ID: 28803487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.